Stay updated on Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.

Latest updates to the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Record History shows a new entry for version 15 on 2025-11-11 with Revision: v3.3.2, and the prior revision v3.2.0 entry dated 2025-11-12 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedOn 2025-11-12, Adverse Events, Outcome Measures (Results), Participant Flow, and Study Status were added to the Record History for NCT04221438. The 2025-10-28 update added item 14 under Study Status.SummaryDifference1%

- Check35 days agoChange DetectedRecord History shows new versions (e.g., 2025-04-29, 2025-05-22, 2025-06-04) with updates to Study Status, Recruitment Status, and Outcome Measures.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference11%

- Check70 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No core content, pricing, stock, or time-slot data were changed.SummaryDifference0.6%

Stay in the know with updates to Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.